Speaker Profile
Chief Medical Director, Formelly Palmetto GBA / MolDX
Biography
Dr. Bien-Willner is the Medical Director of the MolDX program at Palmetto GBA, a Medicare Administrative Contractor (MAC). He is a leader in the Precision Medicine space and practices as a Board-certified Anatomic Pathologist and Molecular Genetic Pathologist. Throughout his career, he has been active in research, development, and advancement of molecular diagnostic services, specifically next generation sequencing. He hasworkedclosely with clinicians to develop clear clinical diagnostic andtreatmentpathways directing Precision Medicine programs for communitycancercenters.Dr. Bien-Willner received his MD and PhD degrees fromBaylorCollege of Medicine, with a PhD in Human Molecular Genetics.Hecompletedhis residency, fellowship, and attained a faculty appointment atWashingtonUniversity in St. Louis prior to leadership roles in laboratoryand biotechcompanies before joining Palmetto GBA.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Christina Curtis, Stanford
PMWC Award Ceremony
• Joe DeRisi, UCSF / CZ Biohub / Delve Bio (Luminary)
• Alexandre Loupy, Inserm / Paris Transplant Group (Pioneer)
Featured Speakers
• Joe DeRisi, UCSF / CZ Biohub / Delve Bio
• Alexandre Loupy, Inserm / Paris Transplant Group
• Minnie Sarwal, UCSF
• Kiran Khush, Stanford
• Iwijn De Vlaminck, Cornell
• Maarten Naesens, KU Leuven
• Charles Chiu, UCSF
• Michael Snyder, Stanford
• Duncan MacCannell, CDC
• Chaz Langelier, UCSF
• Yoel Sadovsky, Stanford
• Ananth Karumanchi, Cedars-Sinai
• Gabriel Bien-Willner, Palmetto GBA / MolDX
• Dawn Cardeiro, Roche Diagnostics
• Bruce Quinn, Bruce Quinn Associates
Transplant & Organ Health Diagnostics
From biopsy to blood-based monitoring of rejection, injury, and infection.
Blood-Based Omics and Host Response in Infection
Metagenomics and host-response signals for difficult infectious disease cases.
Maternal & Fetal Health
From prenatal screening to actionable maternal and placental biomarkers.
From Signal to Standard of Care
What makes a non-cancer blood test clinically actionable and reimbursable.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
